About MedPlus Health Services Limited

MedPlus Health Services Limited, incorporated on November 30, 2006, is a leading organised retail pharmacy chain in India with an omnichannel model spanning neighbourhood stores and digital platforms. Its portfolio includes pharmaceuticals, wellness items, and FMCG such as OTC medicines, vitamins, medical devices, toiletries, baby care, soaps, detergents, and sanitizers. As of March 31, 2025, operations spanned 13 states and 1 union territory across 700 cities with 4,712 stores, supported by a cluster-based expansion strategy and technology-driven supply chain. The company reported revenue from operations of Rs 6,136.05 crore in FY 2024-25 and PAT of Rs 150.23 crore. MedPlus launched MedPlus-branded pharmaceutical products covering acute and chronic therapies, which reached GMV of H 14,025.52 million (reported as a share of pharmacy revenues) in FY 2024 on a GMV basis, aligning with its focus on quality and affordability. Optival Health Solutions Private Limited is identified as a material subsidiary; exports contribute 0% of turnover. Operations are national, with no international offices.

MedPlus Health Services Limited Business Segment

• Primary revenue streams are retail trade services of pharmaceutical products and medical/orthopaedic goods, contributing 98.24% of turnover (NIC 47721). Diagnostic-imaging services contribute 1.76% of turnover (NIC 86905).

• Geographic split disclosure: Exports constitute 0% of turnover; markets served are exclusively national across 14 states, with 0 international countries served.

MedPlus Health Services Limited Key Management

• Gangadi Madhukar Reddy — Chairman, Managing Director and Chief Executive Officer.

• Dr. Cherukupalli Bhaskar Reddy — Whole Time Director and COO.

• Sujit Kumar Mahato — Chief Financial Officer.

• Manoj Kumar Srivastava — Head – Corporate Secretarial, Company Secretary and Compliance Officer.

• Subrahmanyam Sharma T. — Chief Technology Officer.

• Kandasamy — Head of Supply Chain.

Latest Updates on MedPlus Health Services Limited

• Opened 305 new stores during the year, reinforcing the cluster-led expansion and presence in Delhi-NCR.

• Revenue from operations grew 9.09% to Rs 6,136.05 crore in FY 2024-25; EBITDA was Rs 535.72 crore; PAT increased to Rs 150.23 crore.

• Expanded MedPlus-branded pharmaceutical products across acute and chronic therapies; private label pharma GMV reported at H 14,025.52 million, contributing 17.50% of pharmacy revenues on GMV basis and 11.58% on net reported revenues (FY 2024 reference).

• Affirmed no penalties or strictures by stock exchanges or SEBI related to capital markets during the year; maintained compliance with corporate governance requirements.

• Optival Health Solutions Private Limited continued as a material subsidiary; related-party transaction approval proposed for FY 2025-26 on an arm’s length basis.